Process for the manufacture of idalopirdine via hydrogenation of an imine

US9975850B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9975850-B2
Application numberUS-201715480647-A
CountryUS
Kind codeB2
Filing dateApr 6, 2017
Priority dateApr 8, 2016
Publication dateMay 22, 2018
Grant dateMay 22, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to the preparation of N-(2-(6-fluoro-1H-indol-3-yl)-ethyl)-3-(2,2,3,3-tetrafluoropropoxy)-benzylamine (Compound I), INN-name idalopirdine, and pharmaceutically acceptable salts thereof:

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for the preparation of N-(2-(6-fluoro-1H-indol-3-yl)-ethyl)-3-(2,2,3,3 tetrafluoropropoxy)-benzylamine (Compound (I)), and pharmaceutically acceptable salts thereof, comprising the steps of: (1) reacting Compound (III) and Compound (IV) in a solvent or solvent mixture, with or without removal of water, to thereby form a reaction mixture that comprises Compound (V), and (2) reacting the Compound (V) of the reaction mixture formed in step (1) with hydrogen in the presence of a transition metal catalyst in a solvent or a solvent mixture with or without the presence of a first acid to form said Compound (I), and (3) optionally adding a second acid to precipitate said formed Compound (I) as a salt, wherein said Compound (I), Compound (III), Compound (IV) and Compound (V) are: 2. A process according to claim 1 wherein said step (1) further comprises cooling the reaction mixture to precipitate Compound (V) as a solid and Compound (V) is isolated. 3. The process according to claim 1 , wherein Compound (V) is formed in an alcoholic solvent. 4. The process according to claim 3 , wherein said alcoholic solvent is 2-propanol. 5. The process according to claim 1 , wherein Compound (V) is formed in a hydrocarbon solvent. 6. The process according to claim 5 , wherein said hydrocarbon solvent is toluene or heptane or a mixture of toluene and heptane. 7. The process according to claim 1 , wherein water is removed by azeotropical separation in step (1). 8. The process according to claim 1 , wherein the temperature in which Compound (V) is formed is between 0° C. and 100° C. 9. The process according to claim 2 , wherein precipitation of Compound (V) is done by cooling the mixture to between −10° C. and 30° C. 10. The process according to claim 1 , wherein the purity of Compound (III) and Compound (IV) is in the range of 90%-99%. 11. The process according to claim 2 , wherein the hydrogenation is carried out in a solvent comprising an ether, ester, alcohol, hydrocarbon or a solvent mixture consisting of at least two solvents independently selected from an ether, ester, alcohol, or hydrocarbon. 12. The process according to claim 1 , wherein the hydrogenation of Compound (V) is carried out at a hydrogen pressure of 1 bar to 10 bar. 13. The process according to claim 1 , wherein the transition metal catalyst comprises iridium, rhodium, platinum, ruthenium, copper or palladium. 14. The process according to claim 13 , wherein the transition metal catalyst is supported on silicium oxide, alumina, carbon or mixtures thereof. 15. The process according to claim 1 , wherein the hydrogenation is carried out in the presence of the first acid, wherein the first acid is one or more acids selected from the group consisting of acetic acid, methane sulfonic acid, trifluoracetic acid, hydrochloric acid, and sulfuric acid. 16. The process according to claim 1 , wherein Compound (I) is precipitated as a salt by addition of the second acid to obtain the corresponding acid addition salt. 17. The process according to claim 1 , wherein Compound (I) is precipitated as a 1:1 HCl salt. 18. A process for the preparation of Compound (V) comprising the steps of: (a) Mixing Compound (III) and Compound (IV) in a solvent or solvent mixture, with or without azeotropical separation of water to thereby form Compound (V); (b) Precipitating said formed Compound (V); and (c) Isolating the precipitated Compound (V); wherein said Compound (III) and Compound (IV) are:

Assignees

Inventors

Classifications

  • Azeotropic distillation · CPC title

  • Tryptamines · CPC title

  • C07D209/14Primary

    Radicals substituted by nitrogen atoms, not forming part of a nitro radical · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9975850B2 cover?
The present invention relates to the preparation of N-(2-(6-fluoro-1H-indol-3-yl)-ethyl)-3-(2,2,3,3-tetrafluoropropoxy)-benzylamine (Compound I), INN-name idalopirdine, and pharmaceutically acceptable salts thereof:
Who is the assignee on this patent?
H Lundbeck As
What technology area does this patent fall under?
Primary CPC classification C07D209/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).